{
  "meta": {
    "title": "00104_Mid_Day_Module_Mixed_Bag-1",
    "url": "https://brainandscalpel.vercel.app/00104-mid-day-module-mixed-bag-1-8bebda7b.html",
    "scrapedAt": "2025-11-29T18:12:59.719Z"
  },
  "questions": [
    {
      "id": 21779,
      "choices": [
        {
          "id": 87080,
          "text": "<p><span style=\"font-size:12pt;\">FSH</span></p>"
        },
        {
          "id": 87081,
          "text": "<p><span style=\"font-size:12pt;\">Estradiol</span></p>"
        },
        {
          "id": 87082,
          "text": "<p><span style=\"font-size:12pt;\">LH</span></p>"
        },
        {
          "id": 87083,
          "text": "<p><span style=\"font-size:12pt;\">Progesterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a menstrual cycle, the primary oocyte undergoes meiotic division to produce 2 unequal daughter cells under the influence of the mid-cycle LH surge. What is the cause of LH surge?&nbsp;</span>(FMGE JANUARY 2023)</p>",
      "unique_key": "Q7354007",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828577,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Estradiol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sustained peak level of estrogen for 24–48 hours in the late follicular phase results in LH surge from the anterior pituitary (positive feedback effect). Effective LH surge persists for about 24 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The growing follicles produce Estradiol which results in positive Feedback causing the <strong>Midcycle LH surge</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1033.jpg\" alt=\"\" width=\"500\" height=\"502\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. FSH</strong>: At the beginning of the follicular phase, the FSH levels produced by the anterior pituitary begin to rise. The <strong>FSH threshold</strong> is the level of FSH needed for follicular recruitment to take place and <strong>FSH Window</strong> is the duration of time the FSH remains above threshold</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. LH</strong>: The LH surge is responsible for <strong>ovulation</strong> which is accompanied by the expulsion of the <strong>first polar body</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Progesterone</strong>: following ovulation there is luteinizations of the follicle which results in increased production of progesterone</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">*Kindly note that <strong>the second polar body</strong> is extruded at the time of fertilization of the ovum by the sperm</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sustained peak level of estrogen for 24–48 hours in the late follicular phase results in LH surge from the anterior pituitary</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynaecology page 68</strong></span></p>",
      "correct_choice_id": 87081,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57638,
      "choices": [
        {
          "id": 229921,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia</span></span></p>"
        },
        {
          "id": 229922,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia of chronic disease</span></span></p>"
        },
        {
          "id": 229923,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></p>"
        },
        {
          "id": 229924,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sideroblastic anemia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is the likely diagnosis in a patient having a &darr; MCV, &darr; MCH, &darr; transferrin saturation, &darr; serum ferritin, and &uarr; Total iron binding capacity? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q6208475",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828578,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Iron deficiency anemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lab findings indicate a <strong>microcytic hypochromic anemia</strong>, as shown by decreased Mean Corpuscular Volume (MCV) and Mean Corpuscular Hemoglobin (MCH).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The iron profile further confirms iron deficiency anemia: low transferrin saturation, low serum ferritin (indicating depleted iron stores), and increased Total Iron Binding Capacity (TIBC), which reflects the body&rsquo;s attempt to bind more iron due to deficiency. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These findings are classic for iron deficiency anemia, where the primary pathology is a lack of iron needed for hemoglobin synthesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Thalassemia</span></strong><span style=\"font-size:12.0pt\">: Thalassemia also presents as microcytic hypochromic anemia, but typically shows normal or increased serum ferritin and normal TIBC due to intact iron stores. The pattern of iron studies here does not fit thalassemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Anemia of chronic disease</span></strong><span style=\"font-size:12.0pt\">: This condition often shows low serum iron, but it is characterized by normal or increased ferritin and decreased TIBC, opposite to the findings in this question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Sideroblastic anemia</span></strong><span style=\"font-size:12.0pt\">: Sideroblastic anemia is characterized by ineffective erythropoiesis and abnormal iron incorporation into hemoglobin, leading to ring sideroblasts in the bone marrow. Serum iron is usually increased, and TIBC is normal or decreased, which does not match the iron deficiency profile described here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iron deficiency anemia is identified by microcytic hypochromic anemia with low serum ferritin, low transferrin saturation, and high TIBC, reflecting the body&rsquo;s response to insufficient iron availability for hemoglobin synthesis.</span></span></span></p>",
      "correct_choice_id": 229923,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13789,
      "choices": [
        {
          "id": 55117,
          "text": "<p><span style=\"font-size:12.0pt;\">Syndesmosis</span></p>"
        },
        {
          "id": 55118,
          "text": "<p><span style=\"font-size:12.0pt;\">Synarthrosis</span></p>"
        },
        {
          "id": 55119,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchondrosis</span></p>"
        },
        {
          "id": 55120,
          "text": "<p><span style=\"font-size:12.0pt;\">Synovial</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What type of joint is demonstrated in the highlighted region of the vertebral articulation shown?&nbsp;</span>(NEET PG 2020)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-889.jpg\" alt=\"\" width=\"300\" height=\"141\"></p>",
      "unique_key": "Q2983683",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828583,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Synovial</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The joint marked in the above image is a synovial joint called the costotransverse and costovertebral joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These are the most common type of joints in the body. The articulating ends of the bones in these joints are covered with articular cartilage. These bones are enclosed within an articular capsule which has an outer fibrous layer (giving it strength) and an inner synovial membrane which secretes synovial fluid (providing lubrication and nutrients to the joint). Examples include the knee joint, elbow joint, and many others.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They are diarthrotic, meaning they are freely movable. The exact range of movement and type of movement (e.g., hinge, pivot, ball-and-socket) varies depending on the specific joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Syndesmosis</strong>: This is a type of fibrous joint where the bones are joined by a ligament or a membrane. The most commonly referred syndesmosis is the one between the tibia and fibula in the leg, held together by the interosseous membrane and the anterior and posterior tibiofibular ligaments.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It allows for a slight movement (making it amphiarthrotic), particularly when the foot is dorsiflexed or plantarflexed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Synarthrosis</strong>: This term describes a joint that allows very minimal or no movement. It encompasses several types of joints including sutures (between skull bones), gomphoses (between a tooth and its socket), and synchondroses (which we'll discuss next).</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">These are largely immovable joints. They serve to provide stability in certain areas of the body, like the skull, where movement is not desired.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Synchondrosis</strong>: This is a subtype of synarthrosis, and it's a type of cartilaginous joint where bones are joined together by hyaline cartilage. A classic example is the joint between the first rib and the sternum, or the epiphyseal plates in growing bones.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">They are immovable (synarthrotic). The primary purpose of these joints is to allow growth of the bone while providing stability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Description of the joint present in the thoracic region are as follows:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/07/screenshot-2023-11-07-181747.jpg\" alt=\"\" width=\"1000\" height=\"742\"></p>",
      "correct_choice_id": 55120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10325,
      "choices": [
        {
          "id": 41266,
          "text": "<p><span style=\"font-size:12.0pt;\">Entamoeba Histolytica</span></p>"
        },
        {
          "id": 41267,
          "text": "<p><span style=\"font-size:12.0pt;\">Giardia lamblia</span></p>"
        },
        {
          "id": 41268,
          "text": "<p><span style=\"font-size:12.0pt;\">Helicobacter pylori</span></p>"
        },
        {
          "id": 41269,
          "text": "<p><span style=\"font-size:12.0pt;\">Entamoeba vermicularis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Flask shaped ulcers in the colon are caused by: (NEET PG 2019)</span></p>",
      "unique_key": "Q3591798",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828580,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Entameoba histolytica</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Flask shaped ulcers&nbsp;</strong>are classically seen in amoebiasis caused by Entamoeba histolytica.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/11_t6QZDZg.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most typical form of amoebic infection, amoebic colitis, starts as a tiny region of necrosis of mucosa that may ulcerate. These ulcerative lesions may grow, develop ulcer edge undermining from trophozoite lytic action, and have a necrotic bed. Due to their structure, such chronic amoebic ulcers are called flask-shaped ulcers (narrow neck and broad base). In addition to the presence of Entamoeba histolytica trophozoites, the ulcer's edge exhibits an inflammatory response with an admixture of polymorphonuclear and mononuclear cells.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-394.jpg\" alt=\"\" width=\"1000\" height=\"482\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Giardia lamblia:</strong> Causes giardiasis, affecting the small intestine and leading to malabsorption and diarrhea but not flask-shaped ulcers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Helicobacter pylori:</strong> Associated with gastric and duodenal ulcers, not typically flask-shaped or located in the colon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Entamoeba vermicularis:</strong> Incorrect nomenclature; possibly meant to refer to a helminth such as Enterobius vermicularis, which causes pinworm infections and does not lead to ulcer formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Entamoeba histolytica is the cause of flask-shaped ulcers in the colon, distinguishing it from other intestinal pathogens due to its invasive capabilities and the characteristic morphology of the ulcers it creates. Understanding these features helps in the differential diagnosis of dysentery and guides appropriate treatment and management strategies.</span></p>",
      "correct_choice_id": 41266,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21111,
      "choices": [
        {
          "id": 84408,
          "text": "<p><span style=\"font-size:12.0pt;\">Conventional Fractionation radiotherapy</span></p>"
        },
        {
          "id": 84409,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypofractionation radiotherapy</span></p>"
        },
        {
          "id": 84410,
          "text": "<p><span style=\"font-size:12.0pt;\">Accelerated Fractionation radiotherapy</span></p>"
        },
        {
          "id": 84411,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperfractionation radiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient diagnosed with cancer is undergoing radiotherapy. She is given a dose of 1.8 to 2 Gy daily for five days a week, for a total treatment duration of 6 to 8 weeks. What among the following explains this type of radiotherapy?</span>(FMGE JANUARY 2023)</p>",
      "unique_key": "Q3029911",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828586,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Conventional Fractionation radiotherapy</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/18/screenshot-2024-05-18-182008.jpg\" alt=\"\" width=\"1000\" height=\"758\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>5 ‘R’s of Fractionated Radiotherapy</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. R</strong>epair - for normal surrounding cells</span></p><p><span style=\"font-size:12.0pt;\"><strong>2. R</strong>epopulation</span></p><p><span style=\"font-size:12.0pt;\"><strong>3. R</strong>eoxygenation</span></p><p><span style=\"font-size:12.0pt;\"><strong>4. R</strong>eassortment /Redistribution</span></p><p><span style=\"font-size:12.0pt;\"><strong>5. R</strong>adiosensitivity</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Conventional Fractionation radiotherapy involves delivering 1.8 to 2 Gy per day, five days a week, for 6 to 8 weeks, allowing for normal tissue recovery between treatments.</span></p>",
      "correct_choice_id": 84408,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5074,
      "choices": [
        {
          "id": 20269,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral malleolus</span></p>"
        },
        {
          "id": 20270,
          "text": "<p><span style=\"font-size:12.0pt;\">Proximal tibia</span></p>"
        },
        {
          "id": 20271,
          "text": "<p><span style=\"font-size:12.0pt;\">Proximal fibular neck</span></p>"
        },
        {
          "id": 20272,
          "text": "<p><span style=\"font-size:12.0pt;\">Tibial shaft</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fracture at which site in leg will cause failure of dorsiflexion of foot?&nbsp;(NEET PG 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture4_9jez52y.jpg\" alt=\"\" width=\"200\" height=\"322\"></p>",
      "unique_key": "Q4127448",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828552,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Proximal fibular neck</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>COMMON PERONEAL NERVE INJURY</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Trauma to the proximal neck of fibula leads to injury of the common peroneal nerve as the nerve winds around the neck of fibula.</span></li><li><span style=\"font-size:12.0pt;\">The CPN injury causes paralysis of muscles of anterior and lateral compartments of the leg, namely tibialis anterior, extensor digitorum longus and brevis, EHL, peroneus tertius (deep peroneal nerve), peroneal longus and brevis (superficial peroneal nerve).</span></li><li><span style=\"font-size:12.0pt;\">Paralysis of these muscles causes failure of foot dorsiflexion i.e., <strong>foot drop</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture5_VX0CrFs.jpg\" alt=\"\" width=\"250\" height=\"360\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">There is also sensory loss on the anterior and lateral sides of the leg, dorsum of the foot and toes, and medial side of the big toe.</span></li><li><span style=\"font-size:12.0pt;\">Lateral border of the foot and lateral side of the little toe are unaffected (supplied by sural nerve, formed by tibial nerve).</span></li><li><span style=\"font-size:12.0pt;\">Medial border of the foot and ball of big toe are also unaffected (supplied by saphenous nerve, branch of femoral nerve).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lateral malleolus:</strong></span> <span style=\"font-size:12.0pt;\">Fracture at the lateral malleolus is Danis-Weber type A fracture of the ankle. In this, there is fracture of the lateral malleolus distal to the syndesmosis. It is usually a stable fracture. It is generally below the tibial plafond, with an intact syndesmosis and deltoid ligament. This fracture does not cause any nerve injury; thus no ankle movement is affected. This fracture has a good prognosis with ankle secured in a splint or cast.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Proximal tibia:</strong></span> <span style=\"font-size:12.0pt;\">Fracture of proximal third of tibia is associated with anterior knee pain (cases operated with intramedullary nailing), non-union, malunion. No nerve is injured with this type of fracture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tibial shaft:</strong></span> <span style=\"font-size:12.0pt;\">Tibial shaft fractures rarely cause nerve injury. Surgical fixation of the fracture with plating puts the superficial peroneal nerve at risk. Saphenous nerve can be injured during placement of locking screws. Transient peroneal nerve palsy after closed nailing can cause EHL weakness and decreased sensation of first dorsal webspace.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Injury to the proximal neck of fibula causes paralysis of dorsiflexion of the foot because around this portion, the common peroneal nerve winds, which supplies the dorsiflexors of the foot.</span></p>",
      "correct_choice_id": 20271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46157,
      "choices": [
        {
          "id": 184247,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea corporis</span></p>"
        },
        {
          "id": 184248,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea cruris</span></p>"
        },
        {
          "id": 184249,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea incognito</span></p>"
        },
        {
          "id": 184250,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea capitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old woman presents to the dermatology clinic with a persistent skin rash. Initially, she had an itchy, ring-shaped rash that partially resolved with a topical ointment. However, within a week of discontinuing the treatment, the itching returned and the rash spread. She denies any new products or environmental exposures. Physical examination reveals poorly demarcated, erythematous plaques with slight scaling scattered over her face, as shown in the image below. There are no vesicles, pustules, or signs of systemic illness. What is the most likely diagnosis?(FMGE JULY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/29/screenshot-2024-05-29-145746.JPG\" alt=\"\" width=\"300\" height=\"371\"></span></p>",
      "unique_key": "Q9274895",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828572,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Tinea incognito</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tinea incognito is a fungal infection that has been altered by the inappropriate use of topical corticosteroids. This condition often presents with atypical features compared to a classic dermatophyte infection. The history of initial improvement with a topical ointment (likely a corticosteroid) followed by a return and worsening of symptoms after discontinuation is characteristic of tinea incognito. The poorly demarcated erythematous plaques with slight scaling observed on physical examination support this diagnosis. The use of corticosteroids suppresses the inflammation and itching temporarily but allows the fungal infection to proliferate more aggressively once the treatment is stopped.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tinea corporis</strong>: This typically presents with well-demarcated, annular, scaly plaques with central clearing and an active border, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tinea cruris</strong>: Usually affects the groin area and is also characterized by well-demarcated borders and central clearing, which is not consistent with the facial distribution and poorly demarcated lesions observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tinea capitis</strong>: This affects the scalp and hair, presenting with scaly patches, hair loss, and sometimes black dots. The facial distribution and presentation described do not match tinea capitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tinea incognito should be suspected when a dermatophyte infection worsens after the use of topical steroids, leading to atypical presentation and distribution of the lesions.</span></p>",
      "correct_choice_id": 184249,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14081,
      "choices": [
        {
          "id": 56285,
          "text": "<p><span style=\"font-size:12.0pt;\">Retroperitoneum</span></p>"
        },
        {
          "id": 56286,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral vessels</span></p>"
        },
        {
          "id": 56287,
          "text": "<p><span style=\"font-size:12.0pt;\">Thoracic cavity</span></p>"
        },
        {
          "id": 56288,
          "text": "<p><span style=\"font-size:12.0pt;\">Dural and subdural spaces</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Apart from the abdomen, which body part is included in e-FAST? (AIIMS NOV 2020)</span></p>",
      "unique_key": "Q7906300",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828590,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Thoracic cavity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>eFAST or extended FAST covers 4 regions of abdomen (epigastrium, right and left paracolic areas and pelvis) and both the thoracic spaces.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Correct. The e-FAST exam extends the basic FAST exam by including views of the thoracic cavity, specifically looking for evidence of pneumothorax or hemothorax. This is done by assessing the pleural spaces on both sides of the chest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Retroperitoneum</strong>: These injuries are often missed on e-FAST.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Peripheral vessels</strong>: Peripheral vessels are not the primary focus of the e-FAST exam. The main goal of e-FAST is to rapidly identify free fluid in specific body cavities that might indicate trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dural and subdural spaces</strong>: These spaces are within the cranial cavity and pertain to the brain. They are not part of the e-FAST exam.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, the e-FAST exam primarily evaluates the abdomen for evidence of trauma, but it also extends to the thoracic cavity to look for signs of pneumothorax or hemothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">E-FAST stands for Extended Focused Assessment with Sonography in Trauma, which is a bedside ultrasound examination used to evaluate trauma patients. It involves the use of a portable ultrasound machine to assess for free fluid in the abdomen, chest, and around the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-131858.png\" alt=\"\" width=\"300\" height=\"238\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In addition to identifying free fluid, e-FAST can also be used to evaluate for other injuries, such as pneumothorax, hemothorax, and pericardial effusion. E-FAST has become a standard of care in trauma evaluation and is a valuable tool in the early detection and treatment of life-threatening injuries.</span></p>",
      "correct_choice_id": 56287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10843,
      "choices": [
        {
          "id": 43338,
          "text": "<p><span style=\"font-size:12.0pt;\">Primordial</span></p>"
        },
        {
          "id": 43339,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary</span></p>"
        },
        {
          "id": 43340,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary</span></p>"
        },
        {
          "id": 43341,
          "text": "<p><span style=\"font-size:12.0pt;\">Tertiary</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 35-year-old nurse in a busy city hospital is focused on infection control for general respiratory illnesses. Regular hand washing with soap and water or using an alcohol-based hand rub is recommended to prevent the spread of infections. This recommendation falls under which level of prevention? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q3299195",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828554,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Primary</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is an example of primary prevention as the risk factor is already present but the disease is being prevented by handwashing. Primary prevention aims to prevent the onset of illness before the disease process begins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Primordial:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Focuses on preventing the development of risk factors themselves, often through policy or societal changes.</span></li><li><span style=\"font-size:12.0pt;\">For example, promoting a healthy lifestyle to prevent the development of high blood pressure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Secondary:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Involves early detection and prompt intervention to prevent progression.</span></li><li><span style=\"font-size:12.0pt;\">For example, screening programs like Pap smears for early detection of cervical cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Tertiary</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Involves managing and reducing the impact of an ongoing illness.</span></li><li><span style=\"font-size:12.0pt;\">For example, providing cardiac rehabilitation after a heart attack to prevent further complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Levels of prevention</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Primordial-Prevention of development of risk factors</span></li><li><span style=\"font-size:12.0pt;\">Primary- Risk factor is present, but disease is being prevented.</span></li><li><span style=\"font-size:12.0pt;\">Secondary-Disease is already present. Screening/early diagnosis and treatment is done in order to prevent the complications.</span></li><li><span style=\"font-size:12.0pt;\">Tertiary- Complications are present, death is being prevented.</span></li></ul>",
      "correct_choice_id": 43339,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16173,
      "choices": [
        {
          "id": 64652,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bronchoscopy</span></span></span></p>"
        },
        {
          "id": 64653,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CT guided biopsy</span></span></span></p>"
        },
        {
          "id": 64654,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sputum cytology</span></span></span></p>"
        },
        {
          "id": 64655,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sputum for AFB</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 45-year-old patient with a history of smoking a pack of cigarettes for the past 15 years presents with hemoptysis. CXR shows a 3 cm upper lobe mass near the apex of the lung. What is the next best step for the management of this patient?</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q3953752",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828589,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) CT guided biopsy</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient has several risk factors for lung cancer, including being over 40 years old, a significant smoking history, and the presence of a mass larger than 2 cm on the chest X-ray. Given these factors, the likelihood of the mass being malignant is high. A <strong>CT guided biopsy is the best next step </strong>because it allows for precise sampling of the mass to confirm the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Bronchoscopy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This would be appropriate if the mass were centrally located or if there were signs of endobronchial involvement. However, because the mass is in the upper lobe, CT guided biopsy is preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Sputum cytology:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This test can sometimes detect cancer cells in the sputum, but it is less reliable, especially for peripheral lung lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sputum for AFB:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This test is used to detect tuberculosis. Given the patient&#39;s history and presentation, tuberculosis is less likely than lung cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For a patient with a significant smoking history and a peripheral lung mass larger than 2 cm, a CT guided biopsy is the next best step to diagnose the nature of the mass.</span></span></span></p>",
      "correct_choice_id": 64653,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10152,
      "choices": [
        {
          "id": 40574,
          "text": "<p><span style=\"font-size:18px;\">Calcium carbonate</span></p>"
        },
        {
          "id": 40575,
          "text": "<p><span style=\"font-size:18px;\">Calcium sulphate</span></p>"
        },
        {
          "id": 40576,
          "text": "<p><span style=\"font-size:18px;\">Calcium bicarbonate</span></p>"
        },
        {
          "id": 40577,
          "text": "<p><span style=\"font-size:18px;\">Magnesium bicarbonate</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which of the options below does not result in water hardness? </strong><i><strong>[NEET PG 2018]</strong></i></span></p>",
      "unique_key": "Q9315160",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828559,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Calcium carbonate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Hardness of water is caused by the presence of dissolved minerals, particularly calcium and magnesium ions. These minerals can come from various sources, such as natural deposits in soil and rocks, or from industrial and domestic activities.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">There are two types of hardness of water:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Temporary&nbsp;</strong>(carbonate) hardness is due to bicarbonates of calcium and magnesium.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Permanent</strong> (non-carbonate) hardness is due to sulphates, chlorides and nitrates.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Hardness of water is defined as the ‘soap destroying power of water’</span></li><li><span style=\"font-size:18px;\">Hardness of water is expressed in terms of: milliequivalents per litre (mEq/litre) of CALCIUM CARBONATE (CaCO3)</span></li><li><span style=\"font-size:18px;\">1 mEq/litre hardness = 50 mg CaCO3 (50 ppm) per litre of water</span></li><li><span style=\"font-size:18px;\">Softening of water is recommended at level of hardness &gt; 3 mEq/litre (&gt;150 mg/litre of Calcium carbonate)</span></li><li><span style=\"font-size:18px;\">Temporary hardness of water is due to Ca++ and Mg++ Bicarbonates</span></li><li><span style=\"font-size:18px;\">Permanent hardness (Non-Carbonate hardness) is due to Calcium &amp; Magnesium salts of Sulfates, Chlorides, Nitrates</span></li><li><span style=\"font-size:18px;\">Four main compounds causing Hardness: Calcium bicarbonates, Magnesium bicarbonates, Calcium sulfates, Magnesium sulfates.</span></li></ul>",
      "correct_choice_id": 40574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13135,
      "choices": [
        {
          "id": 52502,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic chiasma</span></p>"
        },
        {
          "id": 52503,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Occipital lobe</span></p>"
        },
        {
          "id": 52504,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Optic tract</span></p>"
        },
        {
          "id": 52505,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic radiation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is not able to see the lateral fields. He was having a mild headache for a few weeks and now presented to the clinic. Visual field examination shows the following finding. What is the probable site of the lesion based on the image displayed?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/dsgvsdf.jpg\" alt=\"\" width=\"300\" height=\"130\"></span></p>",
      "unique_key": "Q6050035",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828560,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Optic chiasma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The visual field defect in the image is indicative of bitemporal hemianopia, so the probable site of the lesion is the optic chiasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of this is pituitary gland tumours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other causes include suprasellar aneurysms, chronic arachnoiditis, suprasellar tumours like craniopharyngioma and suprasellar meningioma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Occipital lobe:</strong> Lesions here typically cause congruent homonymous hemianopia, where the same visual field is lost in both eyes, not bitemporal defects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Optic tract:</strong> Lesions in the optic tract cause homonymous hemianopia, affecting the same side of the visual field in both eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Optic radiation:</strong> Lesions here also cause homonymous hemianopia, but depending on the location, they might lead to variations like a superior or inferior quadrantanopia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Visual field defects:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/mygfffff.jpg\" alt=\"\" width=\"500\" height=\"416\"></span></p>",
      "correct_choice_id": 52502,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5196,
      "choices": [
        {
          "id": 20757,
          "text": "<p><span style=\"font-size:12.0pt;\">Giemsa stain</span></p>"
        },
        {
          "id": 20758,
          "text": "<p><span style=\"font-size:12.0pt;\">Ziehl-Nielsen stain</span></p>"
        },
        {
          "id": 20759,
          "text": "<p><span style=\"font-size:12.0pt;\">Gram staining</span></p>"
        },
        {
          "id": 20760,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucicarmine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the stain used for identifying cryptococcus? (NEET PG 2019)</span></p>",
      "unique_key": "Q4095402",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828575,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mucicarmine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mucicarmine staining is specifically used to identify Cryptococcus, particularly useful in highlighting the thick polysaccharide capsule that is characteristic of Cryptococcus neoformans, a yeast-like fungus that can cause serious infections, especially in immunocompromised individuals. The mucicarmine stain binds to the acidic polysaccharides of the fungal capsule and stains it a bright red, making it distinctly visible against a light blue background. This staining technique is especially valuable in histopathological diagnosis of cryptococcal infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Giemsa stain:</strong> Primarily used for blood parasites and certain bacteria, it's not specific for fungal structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ziehl-Nielsen stain:</strong> Used to identify acid-fast bacteria, such as Mycobacterium tuberculosis, not fungi.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gram staining:</strong> While it can stain a variety of bacteria, it is generally not effective for encapsulated fungi like Cryptococcus due to its poor affinity for fungal polysaccharide capsules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/24/screenshot-2024-06-24-165942.png\" alt=\"\" width=\"1000\" height=\"748\"></strong></span></p>",
      "correct_choice_id": 20760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16120,
      "choices": [
        {
          "id": 64440,
          "text": "<p><span style=\"font-size:12.0pt;\">Age of the patient</span></p>"
        },
        {
          "id": 64441,
          "text": "<p><span style=\"font-size:12.0pt;\">Size of the tumor</span></p>"
        },
        {
          "id": 64442,
          "text": "<p><span style=\"font-size:12.0pt;\">Hormone receptor staining</span></p>"
        },
        {
          "id": 64443,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of necrosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The Van Nuys grading system for ductal carcinoma in situ does not include:(NEET PG 2018)</span></p>",
      "unique_key": "Q7782775",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828584,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Hormone receptor staining</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hormone receptor status, which determines if the tumor cells have receptors for hormones like estrogen and progesterone, is not included in the VNPI. While hormone receptor status is crucial for managing invasive breast cancers, as it determines potential responses to hormone therapies like tamoxifen, it's not a component of the Van Nuys grading system for DCIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Staining for estrogen and progesterone receptors is not part of the Van Nuys system used for grading DCIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Van Nuys Prognostic Index (VNPI) is a grading system that helps to stratify patients with ductal carcinoma in situ (DCIS) based on several factors to determine the likelihood of recurrence and guide treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Age of the patient: </strong>The age of the patient is one of the factors in the Van Nuys Prognostic Index. Younger age (below 40) is associated with a higher risk of recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Size of the tumor: </strong>Tumor size is an essential factor in the Van Nuys grading system. Larger DCIS lesions (&gt; 4cm) are associated with a higher risk of recurrence. Thus, the size can influence the treatment approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Presence of necrosis: </strong>In DCIS, the presence or absence of necrosis plays a role in determining the prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/screenshot-2024-10-01-125435.jpg\" alt=\"\" width=\"927\" height=\"734\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Van Nuys grading system for ductal carcinoma in situ does not include Hormone receptor staining.</span></p>",
      "correct_choice_id": 64442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11321,
      "choices": [
        {
          "id": 45250,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aschoff nodule</span></span></p>"
        },
        {
          "id": 45251,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudomyxoma</span></span></p>"
        },
        {
          "id": 45252,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caseating granuloma</span></span></p>"
        },
        {
          "id": 45253,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Verrucous tumour</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 17-year-old girl presented with arthritis. She had a history of fever and sore throat 1 week ago. On examination, you hear a pansystolic murmur suggestive of mitral regurgitation. What is the finding you will see in the biopsy?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-172510.jpg\" style=\"height:204px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q3558659",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828550,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Aschoff nodule</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation suggests acute rheumatic fever (ARF), a sequela of untreated or poorly treated streptococcal pharyngitis. ARF can manifest with migratory arthritis, carditis (evidenced by the pansystolic murmur indicative of mitral regurgitation), and other systemic symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aschoff nodules, or Aschoff bodies, are pathognomonic for acute rheumatic fever. These are areas of fibrinoid necrosis surrounded by chronic inflammatory cells, including Anitschkow cells (macrophages with characteristic wavy nuclei). They are found in the heart tissue, especially in the myocardium, and are a hallmark of rheumatic carditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pseudomyxoma:</span></strong><span style=\"font-size:12.0pt\"> Pseudomyxoma peritonei is a condition characterized by the accumulation of mucinous material in the peritoneal cavity, typically originating from a mucinous tumor. It is not related to acute rheumatic fever.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Caseating granuloma:</span></strong><span style=\"font-size:12.0pt\"> Caseating granulomas are characteristic of tuberculosis and certain fungal infections. They consist of a central area of necrosis surrounded by a rim of activated macrophages and lymphocytes. This finding is not associated with rheumatic fever.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Verrucous tumour:</span></strong><span style=\"font-size:12.0pt\"> Verrucous tumors are typically warty growths and are not related to rheumatic fever. They can be associated with certain types of skin cancers or infectious warts but have no connection to the condition described in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with a history of sore throat followed by symptoms such as arthritis and carditis, acute rheumatic fever should be considered. The presence of Aschoff nodules in biopsy is pathognomonic for this condition, confirming the diagnosis.</span></span></span></p>",
      "correct_choice_id": 45250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5940,
      "choices": [
        {
          "id": 23730,
          "text": "<p><span style=\"font-size:12pt;\">6-8 weeks</span></p>"
        },
        {
          "id": 23731,
          "text": "<p><span style=\"font-size:12pt;\">11-14 weeks</span></p>"
        },
        {
          "id": 23732,
          "text": "<p><span style=\"font-size:12pt;\">14-16 weeks</span></p>"
        },
        {
          "id": 23733,
          "text": "<p><span style=\"font-size:12pt;\">16-20 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the ideal time for nuchal translucency evaluation? (NEET PG 2019)</span></p>",
      "unique_key": "Q1069719",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828567,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 11-14 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Nuchal Translucency (NT):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Definition:</strong> Nuchal translucency refers to the maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</span></li><li><span style=\"font-size:12pt;\"><strong>Significance:</strong> An increased NT measurement is associated with an increased risk for fetal aneuploidy (such as Down syndrome) and various structural anomalies including cardiovascular defects, hydrops fetalis, and cystic hygroma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Timing:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">NT is measured between <strong>11 weeks</strong> and <strong>13 weeks 6 days</strong> (or <strong>11-14 weeks</strong>) of gestation. This time frame is critical as it ensures the accuracy of the measurement and its correlation with potential anomalies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Measurement Criteria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Crown-Rump Length (CRL):</strong> Should be between 45-84 mm.</span></li><li><span style=\"font-size:12pt;\"><strong>Fetal Position:</strong> Fetus should be in the mid-sagittal plane and in a neutral position.</span></li><li><span style=\"font-size:12pt;\"><strong>Image Quality:</strong> The image must be magnified, and the widest space should be measured.</span></li><li><span style=\"font-size:12pt;\"><strong>Caliper Placement:</strong> The ‘+’ calipers must be placed on the inner borders of the nuchal space, ensuring the amnion is seen separately.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Screening Efficiency:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>NT Alone:</strong> Provides a 65% detection rate for Down syndrome.</span></li><li><span style=\"font-size:12pt;\"><strong>Combined Test:</strong> When combined with the Dual Marker test (beta hCG and PAPP-A), the detection rate for Down syndrome improves to 80%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 6-8 weeks:</strong> This is too early for accurate NT measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 14-16 weeks:</strong> This is beyond the optimal time frame for NT evaluation, reducing the effectiveness of the screening.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 16-20 weeks:</strong> This period is too late for NT measurement, which should be performed in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The ideal time for nuchal translucency evaluation is between 11-14 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-77.jpg\" alt=\"\" width=\"300\" height=\"241\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 860, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23731,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55345,
      "choices": [
        {
          "id": 220841,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac arrhythmias</span></p>"
        },
        {
          "id": 220842,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypotonia</span></p>"
        },
        {
          "id": 220843,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of DTRs (Deep Tendon Reflexes)</span></p>"
        },
        {
          "id": 220844,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory depression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The 1<sup>st</sup></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">sign to be seen in Mg toxicity in a patient receiving MgSO<sub>4</sub> for eclampsia is? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2783853",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828571,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Loss of DTRs (Deep Tendon Reflexes)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is <strong>Loss of DTRs (Deep Tendon Reflexes)</strong>. When administering magnesium sulfate (MgSO<sub>4</sub>) for eclampsia, it is crucial to monitor for signs of magnesium toxicity. The first clinical sign indicating toxicity is the loss of deep tendon reflexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Detailed Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Magnesium Sulfate in Eclampsia</strong>: MgSO<sub>4 </sub>is used to prevent seizures in patients with eclampsia. While effective, it has a narrow therapeutic range, making monitoring for toxicity essential.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Monitoring Signs</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Loss of DTRs</strong>: This is the earliest sign of magnesium toxicity. Clinicians regularly check for the presence of deep tendon reflexes to ensure they are intact.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Respiratory Depression</strong>: Following the loss of DTRs, respiratory depression can occur if magnesium levels continue to rise.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cardiac Arrest</strong>: In severe cases, unchecked magnesium toxicity can lead to cardiac arrest.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Cardiac arrhythmias</strong>: While significant, this is a later sign of magnesium toxicity and typically occurs after respiratory depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Hypotonia</strong>: This can be a symptom of magnesium toxicity but is not the first sign observed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Respiratory depression</strong>: This follows the loss of deep tendon reflexes and is a critical sign of advancing magnesium toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Loss of Deep Tendon Reflexes (DTRs)&nbsp;</strong>is the first clinical sign of magnesium toxicity in patients receiving MgSO<sub>4</sub> for eclampsia. Continuous monitoring of DTRs is crucial to detect early toxicity and prevent severe complications.</span></p>",
      "correct_choice_id": 220843,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54905,
      "choices": [
        {
          "id": 219081,
          "text": "<p><span style=\"font-size:12.0pt;\">Ossicular fixation with intact tympanic membrane</span></p>"
        },
        {
          "id": 219082,
          "text": "<p><span style=\"font-size:12.0pt;\">Ossicular fixation without intact tympanic membrane</span></p>"
        },
        {
          "id": 219083,
          "text": "<p><span style=\"font-size:12.0pt;\">Erosion with intact tympanic membrane</span></p>"
        },
        {
          "id": 219084,
          "text": "<p><span style=\"font-size:12.0pt;\">Erosion without intact tympanic membrane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman presented with hearing loss. On PTA, the amount of hearing loss was 56dB: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7432686",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828562,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) Ossicular fixation with intact tympanic membrane</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Otosclerosis is a common cause of progressive hearing loss, particularly in young adults and often worsens during pregnancy due to hormonal changes. The condition is characterized by abnormal bone growth around the stapes bone in the middle ear, leading to its <strong>fixation</strong>. This fixation prevents the stapes from vibrating in response to sound waves, thereby reducing the transmission of sound to the inner ear and causing hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In otosclerosis, the tympanic membrane (eardrum) typically appears normal upon examination. The hearing loss in otosclerosis is conductive, meaning it is due to a problem in the outer or middle ear, which transmits sound to the inner ear. A pure-tone audiogram (PTA) showing a 56dB hearing loss indicates significant conductive hearing impairment, consistent with otosclerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ossicular fixation without intact tympanic membrane</strong>: This condition is not typical of otosclerosis. Ossicular fixation in otosclerosis occurs with an intact tympanic membrane. A non-intact tympanic membrane would suggest a different pathology, such as chronic otitis media.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Erosion with intact tympanic membrane</strong>: Ossicular erosion with an intact tympanic membrane is not characteristic of otosclerosis. Ossicular erosion is more commonly seen in chronic suppurative otitis media (CSOM), particularly in its cholesteatoma form, which can erode the ossicles but usually involves perforation of the tympanic membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Erosion without intact tympanic membrane</strong>: This is also not typical of otosclerosis. Erosion without an intact tympanic membrane again points towards chronic otitis media, especially with complications leading to ossicular erosion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Otosclerosis often presents as progressive conductive hearing loss with an intact tympanic membrane, and the hearing loss can worsen during pregnancy. The classic finding is ossicular fixation, particularly of the stapes bone.</span></p>",
      "correct_choice_id": 219081,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55366,
      "choices": [
        {
          "id": 220925,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay-Sachs disease</span></p>"
        },
        {
          "id": 220926,
          "text": "<p><span style=\"font-size:12.0pt;\">Fabry's disease</span></p>"
        },
        {
          "id": 220927,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher's disease</span></p>"
        },
        {
          "id": 220928,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Gierke disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cherry red spot without organomegaly is seen in which of the following disorders?&nbsp;(FMGE JULY 2024)</span></p>",
      "unique_key": "Q5529859",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828551,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tay-Sachs disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tay-Sachs disease is a lysosomal storage disorder caused by a deficiency in the enzyme Hexosaminidase A. This condition leads to the accumulation of GM2 ganglioside in the neurons, which can be observed as a <strong>cherry red spot in the macula of the retina</strong>. However, unlike other sphingolipidoses, Tay-Sachs disease is characterized by the <strong>absence of hepatosplenomegaly</strong>.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-103228.png\" alt=\"\" width=\"300\" height=\"225\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fabry's disease</strong>: Fabry's disease is caused by a deficiency in the enzyme α-Galactosidase and is an X-linked recessive disorder. This condition does not typically present with a cherry red spot and is associated with other symptoms such as angiokeratomas and renal complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gaucher's disease</strong>: Gaucher's disease results from a deficiency in the enzyme β-Glucosidase. It is typically associated with hepatosplenomegaly, and while cherry red spots can rarely be seen, it is not a common feature of the disease. The presence of hepatosplenomegaly distinguishes it from Tay-Sachs disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Von Gierke disease</strong>: Von Gierke disease (Glycogen storage disease type I) is not a lysosomal storage disorder or a sphingolipidosis. It is associated with glycogen metabolism and does not present with cherry red spots. This disease also features hepatomegaly, which is not consistent with the condition described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">All sphingolipidoses are autosomal recessive except for Fabry's disease, which is X-linked recessive.</span></li><li><span style=\"font-size:12.0pt;\">All sphingolipidoses are associated with mental retardation except for Gaucher's disease and Fabry's disease.</span></li><li><span style=\"font-size:12.0pt;\">All sphingolipidoses have hepatosplenomegaly except for Tay-Sachs and Krabbe's disease.</span></li><li><span style=\"font-size:12.0pt;\">All sphingolipidoses have a cherry red spot in the eye except for Fabry's and Gaucher's disease.</span></li><li><span style=\"font-size:12.0pt;\">Sphingolipidoses with angiokeratoma include GM1 gangliosidosis and Fabry's disease.</span></li><li><span style=\"font-size:12.0pt;\">Krabbe's disease is also known as Globoid cell leukodystrophy.</span></li><li><span style=\"font-size:12.0pt;\">Sphingolipidoses resembling rheumatoid arthritis or idiopathic juvenile arthritis include Farber's disease.</span></li><li><span style=\"font-size:12.0pt;\">Sphingolipidoses resembling sickle cell crisis include Fabry's disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:11pt;\">&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tay-Sachs disease is characterized by the presence of a cherry red spot in the retina without organomegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Niemann-Pick disease - characterized by the presence of a cherry red spot in the retina with splenomegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-103353.png\" alt=\"\" width=\"1000\" height=\"406\"></span></p>",
      "correct_choice_id": 220925,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5899,
      "choices": [
        {
          "id": 23566,
          "text": "<p><span style=\"font-size:12pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 23567,
          "text": "<p><span style=\"font-size:12pt;\">Placenta previa</span></p>"
        },
        {
          "id": 23568,
          "text": "<p><span style=\"font-size:12pt;\">Hydramnios</span></p>"
        },
        {
          "id": 23569,
          "text": "<p><span style=\"font-size:12pt;\">Preterm labour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A hypertensive pregnant woman with abdominal pain, bleeding per vaginum, and loss of fetal movements. What is the probable diagnosis?&nbsp;</span>(INICET NOV 2020)</p>",
      "unique_key": "Q7329645",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828576,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Abruptio placenta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Abruptio placentae, also known as placental abruption, commonly occurs in hypertensive disorders of pregnancy. It is characterized by the premature separation of the placenta from the uterus, leading to painful vaginal bleeding, abdominal pain, and often fetal distress or fetal death. The uterus may be tonically contracted in such cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Hypertensive Disorders:</strong> Abruptio placentae is frequently associated with hypertensive disorders of pregnancy.</span></li><li><span style=\"font-size:12pt;\"><strong>Clinical Presentation:</strong> Painful vaginal bleeding, abdominal pain, and loss of fetal movements are hallmark signs.</span></li><li><span style=\"font-size:12pt;\"><strong>Uterine Contraction:</strong> The uterus may feel firm and tender, indicating a tonic contraction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Placenta previa:</strong> Placenta previa involves painless vaginal bleeding due to the placenta covering the cervix. It generally does not cause decreased fetal movements unless there is severe bleeding leading to maternal and fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Hydramnios:</strong> Hydramnios (polyhydramnios) involves excessive amniotic fluid and does not typically present with bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Preterm labor:</strong> Preterm labor typically does not present with bleeding and is characterized by regular uterine contractions leading to cervical changes before 37 weeks of gestation. Prematurity in preterm labor is iatrogenic if induced.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Abruptio placenta should be suspected in a hypertensive pregnant woman presenting with painful vaginal bleeding, abdominal pain, and loss of fetal movements, as it is commonly associated with hypertensive disorders and presents with these clinical features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams Textbook of obstetrics 26<sup>th</sup> edition pg 1944</strong></span></p>",
      "correct_choice_id": 23566,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43612,
      "choices": [
        {
          "id": 174111,
          "text": "<p><span style=\"font-size:12.0pt;\">Extradural hemorrhage</span></p>"
        },
        {
          "id": 174112,
          "text": "<p><span style=\"font-size:12.0pt;\">Intraparenchymal hemorrhage</span></p>"
        },
        {
          "id": 174113,
          "text": "<p><span style=\"font-size:12.0pt;\">Subarachnoid hemorrhage</span></p>"
        },
        {
          "id": 174114,
          "text": "<p><span style=\"font-size:12.0pt;\">Subdural hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the hemorrhage shown in the given image.&nbsp;</span><span style=\"font-size:14px;\">(FMGE JANUARY 2024)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-110218.JPG\" alt=\"\" width=\"300\" height=\"285\"></p>",
      "unique_key": "Q7327212",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828568,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Subdural hemorrhage</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subdural hemorrhages occur beneath the dura mater but outside the brain parenchyma, between the dura and the arachnoid layers. They typically appear as crescent-shaped hyperdense areas on CT scans, conforming to the brain surface and often crossing suture lines, unlike extradural hemorrhages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Extradural Hemorrhage (Epidural Hemorrhage)</strong>: This type of hemorrhage occurs between the inner surface of the skull and the dura mater. On imaging, it usually appears as a lens-shaped (biconvex) hyperdense area that does not cross suture lines due to the attachment of the dura to the sutures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intraparenchymal Hemorrhage</strong>: This refers to bleeding within the brain tissue itself. On CT scans, intraparenchymal hemorrhages appear as irregular or rounded hyperdense areas within the brain parenchyma. They are often surrounded by a low-density area due to edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Subarachnoid Hemorrhage</strong>: This type of hemorrhage occurs in the subarachnoid space, between the arachnoid mater and the pia mater, covering the brain. It usually presents as a diffuse area of increased density in the spaces around the brain, particularly visible in the sulci and cisterns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subdural hemorrhages, typically appear as crescent-shaped hyperdense areas on CT scans and in particular, require timely intervention to manage increased intracranial pressure and prevent permanent damage or death. They can present with symptoms ranging from mild headaches to severe neurological deficits, depending on the extent of the bleeding.</span></p>",
      "correct_choice_id": 174114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55417,
      "choices": [
        {
          "id": 221129,
          "text": "<p><span style=\"font-size:18px;\">Splenic rupture</span></p>"
        },
        {
          "id": 221130,
          "text": "<p><span style=\"font-size:18px;\">Thrombocytopenia</span></p>"
        },
        {
          "id": 221131,
          "text": "<p><span style=\"font-size:18px;\">Hairy cell leukemia</span></p>"
        },
        {
          "id": 221132,
          "text": "<p><span style=\"font-size:18px;\">Bone marrow failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Splenectomy is contraindicated in which of the following conditions? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7483548",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828566,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Bone marrow failure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Bone marrow failure</strong> often seen in aplastic anemia, involves the failure of the bone marrow to produce sufficient blood cells. The spleen is not involved in this pathology, so splenectomy would not be beneficial. The problem lies within the bone marrow, not the spleen, making splenectomy contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Splenic rupture:</strong> Splenectomy is commonly indicated in cases of splenic rupture, whether due to trauma or iatrogenic causes, to prevent life-threatening hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Thrombocytopenia:</strong> In cases of idiopathic thrombocytopenic purpura (ITP), splenectomy can be an effective treatment option to achieve durable remission, although it is not the first-line treatment.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Corticosteroids and other treatments are often tried first.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Hairy cell leukemia:</strong> Splenectomy may be indicated in hairy cell leukemia in cases of massive splenomegaly or persistent cytopenias to alleviate symptoms and improve blood counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Splenectomy is contraindicated in bone marrow failure, as the underlying issue resides in the bone marrow's inability to produce blood cells.</span></p>",
      "correct_choice_id": 221132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54810,
      "choices": [
        {
          "id": 218705,
          "text": "<p><span style=\"font-size:12.0pt;\">Sub-acute intestinal obstruction</span></p>"
        },
        {
          "id": 218706,
          "text": "<p><span style=\"font-size:12.0pt;\">Paralytic ileus</span></p>"
        },
        {
          "id": 218707,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural effusion</span></p>"
        },
        {
          "id": 218708,
          "text": "<p><span style=\"font-size:12.0pt;\">Hollow viscus perforation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following pathology is shown in the image?&nbsp;(FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-162901.png\" alt=\"\" width=\"300\" height=\"309\"></span></p>",
      "unique_key": "Q5214122",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828569,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>&nbsp;Ans. D) Hollow viscus perforation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image provided shows a typical sign of free air under the right dome of the diaphragm. This finding is highly indicative of a hollow viscus perforation. When there is a perforation in any part of the gastrointestinal tract, air can escape into the peritoneal cavity. This air then rises to the highest point in the abdomen when the patient is in an upright position, which is under the diaphragm, and is visible on an upright chest X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Subacute intestinal obstruction:</strong> This condition would not present with free air under the diaphragm. Instead, it would typically show dilated bowel loops with air-fluid levels on an abdominal X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Paralytic ileus:</strong> Paralytic ileus would also not present with free air under the diaphragm. It usually shows diffusely dilated bowel loops without a transition point on imaging studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pleural effusion:</strong> A pleural effusion involves fluid accumulation in the pleural cavity and would not present with air under the diaphragm. It typically shows fluid in the pleural space on a chest X-ray, often blurring the costophrenic angle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of free air under the diaphragm on an upright chest X-ray is a classic radiographic finding indicative of a hollow viscus perforation. This is a critical sign that should prompt immediate medical evaluation and intervention.</span></p>",
      "correct_choice_id": 218708,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10882,
      "choices": [
        {
          "id": 43494,
          "text": "<p><span style=\"font-size:12.0pt;\">Women education and empowerment</span></p>"
        },
        {
          "id": 43495,
          "text": "<p><span style=\"font-size:12.0pt;\">Children and new-born care.</span></p>"
        },
        {
          "id": 43496,
          "text": "<p><span style=\"font-size:12.0pt;\">Screening and treatment for STI and RTI</span></p>"
        },
        {
          "id": 43497,
          "text": "<p><span style=\"font-size:12.0pt;\">Safe motherhood</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT typically recognized as a primary component of the RCH program? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q2260932",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828588,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Women education and empowerment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While education and empowerment of women are crucial for overall health improvement, they are not specifically listed as a primary component of the RCH program.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Reproductive and Child Health (RCH) program focuses on specific health services to improve the health of mothers and children. The primary components of the RCH program include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Children and newborn care:</strong> Services aimed at ensuring the health and well-being of children and newborns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Screening and treatment for STI and RTI:</strong> Control and prevention of reproductive tract infections (RTI) and sexually transmitted infections (STI).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Safe motherhood:</strong> Initiatives to ensure the health and safety of mothers during pregnancy, childbirth, and the postpartum period.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Component of RCH program -&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Community Needs Assessment Approach (CNAA)</span></li><li><span style=\"font-size:12.0pt;\">Integrated packages of services for mother and child</span></li><li><span style=\"font-size:12.0pt;\">MTP services at PHC and safe abortion</span></li><li><span style=\"font-size:12.0pt;\">Control and prevention of RTI/STI</span></li><li><span style=\"font-size:12.0pt;\">Adolescent health</span></li><li><span style=\"font-size:12.0pt;\">Services in urban slums</span></li><li><span style=\"font-size:12.0pt;\">Improving quality of services</span></li><li><span style=\"font-size:12.0pt;\">Unmet needs and sub-centre action plans</span></li><li><span style=\"font-size:12.0pt;\">Communication strategy</span></li><li><span style=\"font-size:12.0pt;\">Gender sensitiveness</span></li><li><span style=\"font-size:12.0pt;\">Greater involvement of Panchayati Raj Institutions (PRIs), NGOs and community</span></li></ul>",
      "correct_choice_id": 43494,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54970,
      "choices": [
        {
          "id": 219341,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazinamide</span></p>"
        },
        {
          "id": 219342,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        },
        {
          "id": 219343,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid</span></p>"
        },
        {
          "id": 219344,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethambutol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with diminution of vision. He has a H/o ATT intake. The causative drug is: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5749677",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828556,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ethambutol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethambutol is the most likely causative drug for vision problems in patients taking anti-tubercular therapy (ATT). It can cause toxic optic neuropathy, leading to diminution of vision. This side effect is dose-dependent and usually reversible if detected early and the drug is discontinued. Ethambutol primarily affects the optic nerve, causing decreased visual acuity, altered color perception (especially red-green color blindness), and central scotomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Toxic Amblyopia caused by drugs:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Ethambutol</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Tobacco</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Chloroquine</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Hydroxychloroquine</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Quinine</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Ethyl Alcohol</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Methyl Alcohol</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thiazinamide:</strong> This drug is not commonly used in ATT and is not typically associated with vision problems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Rifampicin:</strong> While an important component of ATT, rifampicin is not primarily associated with vision changes. Its main side effects include hepatotoxicity and orange discoloration of body fluids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Isoniazid:</strong> Although isoniazid can cause peripheral neuropathy, it is not typically associated with optic neuropathy or vision changes. Its main neurological side effect is peripheral neuropathy, which can be prevented by administering pyridoxine (vitamin B6).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethambutol is the anti-tubercular drug most commonly associated with toxic optic neuropathy, causing diminution of vision in patients on ATT. Regular ophthalmic monitoring is crucial for patients on ethambutol to detect early signs of toxicity</span></p>",
      "correct_choice_id": 219344,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10149,
      "choices": [
        {
          "id": 40562,
          "text": "<p><span style=\"font-size:18px;\">90/100</span></p>"
        },
        {
          "id": 40563,
          "text": "<p><span style=\"font-size:18px;\">100/110</span></p>"
        },
        {
          "id": 40564,
          "text": "<p><span style=\"font-size:18px;\">(90-10)/1000</span></p>"
        },
        {
          "id": 40565,
          "text": "<p><span style=\"font-size:18px;\">90/1000</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>In a screening examination conducted on a population of 1000 individuals for diabetes mellitus (DM), 90 individuals tested positive. Subsequently, a gold standard test for DM was performed, identifying 100 positive cases. What is the calculated sensitivity? </strong><i><strong>[NEET PG 2018]</strong></i></span></p>",
      "unique_key": "Q1347427",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) 90/100</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In given question, the following data are provided:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total population = 1000</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total diseased people = 100 (identified by gold standard test)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total number of diabetics identified initially = 90, thus</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">total positive identified by screening test =90</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-092605.png\" alt=\"\" width=\"1000\" height=\"216\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Therefore:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Sensitivity = TP/(TP+FN) =90/ (90+10) = 90/100 = 90%</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Sensitivity is the proportion of true positive cases correctly identified by a screening test out of all actual positive cases identified by the gold standard test.</span></p>",
      "correct_choice_id": 40562,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46427,
      "choices": [
        {
          "id": 185327,
          "text": "<p><span style=\"font-size:12.0pt;\">Objective</span></p>"
        },
        {
          "id": 185328,
          "text": "<p><span style=\"font-size:12.0pt;\">Target</span></p>"
        },
        {
          "id": 185329,
          "text": "<p><span style=\"font-size:12.0pt;\">Goal</span></p>"
        },
        {
          "id": 185330,
          "text": "<p><span style=\"font-size:12.0pt;\">Principle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not constrained by time? (FMGE JULY 2023)</span></p>",
      "unique_key": "Q4005643",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828555,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Goal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A goal is <strong>the ultimate desired state</strong> that a health program aims to achieve. It is not constrained by time, meaning that a goal does <strong>not have a specific timeline</strong> associated with it. Additionally, a goal is <strong>not necessarily attainable</strong>, as it represents the ultimate desired outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Objective:&nbsp;</strong> An objective is a <strong>specific, planned activity</strong> in a health program. Objectives are designed to help achieve the goal and are usually associated with a <strong>timeline</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Target:&nbsp;</strong> A target is the <strong>degree of achievement</strong> of objectives and is always associated with a <strong>timeline.</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Principle:&nbsp;</strong> The principles are generally <strong>guidelines or fundamental truths</strong> and do not specify timelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of health programs, a goal is the ultimate desired state and is not constrained by time or resources. It represents an \"<strong>all or none\" phenomenon</strong> and may not always be attainable.</span></p>",
      "correct_choice_id": 185329,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5536,
      "choices": [
        {
          "id": 22116,
          "text": "<p><span style=\"font-size:12.0pt;\">Filgrastim</span></p>"
        },
        {
          "id": 22117,
          "text": "<p><span style=\"font-size:12.0pt;\">Darbepoetin</span></p>"
        },
        {
          "id": 22118,
          "text": "<p><span style=\"font-size:12.0pt;\">Oprelvekin</span></p>"
        },
        {
          "id": 22119,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron dextran</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 68-year-old male patient on cancer chemotherapy developed neutropenia. Which of the following drug is used to increase the immunity in this person? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q7434468",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828587,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Filgrastim</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Filgrastim is a G-CSF (Granulocyte Colony Stimulating Factor) that can be used for chemotherapy induced neutropenia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#192027;font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>B. Darbepoetin</strong>: It is an Erythropoietin analogue which is used in the treatment of anemia due to CKD and bone marrow suppression.</span><br>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#192027;font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>C. Oprelvekin</strong>: It is an IL-11 analogue and stimulates the proliferation of megakaryocytes. It is useful in Thrombocytopenia.</span><br>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#192027;font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>D. Iron Dextran</strong>: It is a parenteral iron preparation which is used to treat Iron deficiency anemia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Filgrastim is the drug used to increase immunity in patients with chemotherapy-induced neutropenia. It works by stimulating the production of neutrophils, thereby reducing the risk of infection. Other drugs like darbepoetin, oprelvekin, and iron dextran are used for different hematological conditions and do not directly increase neutrophil counts or improve immunity in neutropenic patients.</span></p>",
      "correct_choice_id": 22116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14383,
      "choices": [
        {
          "id": 57493,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical spine stabilization, intubation, IV cannulation, CECT</span></p>"
        },
        {
          "id": 57494,
          "text": "<p><span style=\"font-size:12.0pt;\">Intubation, cervical spine stabilization, IV cannulation, CECT</span></p>"
        },
        {
          "id": 57495,
          "text": "<p><span style=\"font-size:12.0pt;\">IV cannulation, cervical spine stabilization, intubation, CECT</span></p>"
        },
        {
          "id": 57496,
          "text": "<p><span style=\"font-size:12.0pt;\">IV cannulation, intubation, CECT, cervical spine stabilization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a patient who presents to the casualty with an RTA, what is the correct sequence of management? (INICET NOV 2022)</span></p>",
      "unique_key": "Q1655198",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828564,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cervical spine stabilization, intubation, IV cannulation, CECT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cervical spine stabilization, intubation, IV cannulation, CECT<strong> </strong>is the correct sequence of management in a patient who presents to the casualty with an RTA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The steps in Advanced Trauma Life Support (ATLS) include the following: primary survey with simultaneous resuscitation, secondary survey, and definitive care.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ABCDE of trauma care include Airway assessment and protection (maintain cervical spine stabilization when appropriate), Breathing and ventilation assessment, Circulation assessment, Disability assessment, and Exposure, with environmental control. During airway securing, cervical spine should be stabilised first (with a hard cervical collar) prior to attempting any manoeuvres like endotracheal intubation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adjuncts to the primary survey include blood tests, ECG, pulse oximetry, urinary and gastric catheters, and radiographs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Specialized imaging like CECT should be considered after the secondary survey and only when the patient is stable after initial resuscitation.</span></p>",
      "correct_choice_id": 57493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20501,
      "choices": [
        {
          "id": 81966,
          "text": "<p><span style=\"font-size:12pt;\">Increased intracranial pressure</span></p>"
        },
        {
          "id": 81967,
          "text": "<p><span style=\"font-size:12pt;\">IVC compression</span></p>"
        },
        {
          "id": 81968,
          "text": "<p><span style=\"font-size:12pt;\">Heavy meals</span></p>"
        },
        {
          "id": 81969,
          "text": "<p><span style=\"font-size:12pt;\">Excessive venous pooling at the feet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman at 36 weeks of gestation presents to you with complaints of feeling light-headedness and dizziness when she lies on her back and feels relieved if she lies on her side or when walks. What is the most likely reason behind this?&nbsp;</span>(NEET PG 2023)</p>",
      "unique_key": "Q2892728",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828565,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) IVC compression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The symptoms of light-headedness and dizziness that the pregnant woman experiences when lying on her back, which are relieved by lying on her side or walking, are indicative of inferior vena cava (IVC) compression. In the supine position during late pregnancy, the gravid uterus compresses the IVC, which can decrease venous return to the heart. This condition, known as supine hypotensive syndrome, leads to reduced cardiac output and can cause symptoms such as dizziness, light-headedness, and a decreased supply of oxygen and nutrients to vital organs.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Supine Hypotensive Syndrome:</strong> This occurs when the enlarged uterus compresses the IVC, reducing venous return to the heart, leading to symptoms like dizziness and light-headedness.</span></li><li><span style=\"font-size:12pt;\"><strong>Relief by changing position:</strong> Symptoms are relieved when the woman lies on her side or walks because these positions alleviate the pressure on the IVC, improving venous return and cardiac output.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increased intracranial pressure:</strong> This would present with symptoms such as headache, vomiting, visual disturbances, and altered mental status, not positional dizziness relieved by lying on the side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Heavy meals:</strong> While heavy meals can cause discomfort, they are unlikely to cause the specific positional symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Excessive venous pooling at the feet:</strong> This might cause symptoms such as swelling and discomfort in the legs but not the specific positional dizziness described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Inferior vena cava compression by the gravid uterus in late pregnancy can cause supine hypotensive syndrome, leading to light-headedness and dizziness when lying on the back, which is relieved by lying on the side or walking.</span></p>",
      "correct_choice_id": 81967,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46454,
      "choices": [
        {
          "id": 185435,
          "text": "<p><span style=\"font-size:12.0pt;\">Nevirapine X 6 weeks</span></p>"
        },
        {
          "id": 185436,
          "text": "<p><span style=\"font-size:12.0pt;\">Nevirapine X 6 months</span></p>"
        },
        {
          "id": 185437,
          "text": "<p><span style=\"font-size:12.0pt;\">Nevirapine + Zidovudine X 6 weeks</span></p>"
        },
        {
          "id": 185438,
          "text": "<p><span style=\"font-size:12.0pt;\">Nevirapine + Zidovudine X 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">HIV positive woman, not on any treatment, delivers a baby. Initial treatment for the newborn will include:(FMGE JULY 2023)</span></p>",
      "unique_key": "Q7948868",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828573,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C)&nbsp;Nevirapine + Zidovudine X 6 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Low-risk infants:&nbsp;</strong></span></p><ul><li><span style=\"font-size:16px;\">Infants born to mothers with suppressed viral load (&lt;1000 copies/ml) done any time after 32 weeks of pregnancy up to delivery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><u>ARV Prophylaxis Options:</u></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Syrup Nevirapine (NVP) or</span></li><li><span style=\"font-size:16px;\">Syrup Zidovudine# (in situations where NVP will not be effective):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Infant born to a mother with confirmed HIV-2 or HIV-1 and HIV-2 combined infections</span></li><li><span style=\"font-size:16px;\">Infant born to a mother who had received single dose of NVP during earlier pregnancy or delivery</span></li><li><span style=\"font-size:16px;\">Infant born to a mother who is on PI-based ART regimen due to treatment failure</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><u>Duration of ARV prophylaxis:</u></span></p><ul><li><span style=\"font-size:16px;\">From birth till 6 weeks of age</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>High-risk infants</strong></span></p><ul><li><span style=\"font-size:16px;\">Infants born to HIV-positive mother not on ART</span></li><li><span style=\"font-size:16px;\">Maternal viral load not done after 32 weeks of pregnancy till delivery</span></li><li><span style=\"font-size:16px;\">Maternal viral load not suppressed between 32 weeks of pregnancy till delivery</span></li><li><span style=\"font-size:16px;\">Mother newly identified HIV positive within 6 weeks of delivery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><u>Options for dual prophylaxis:</u></span></p><ul><li><span style=\"font-size:16px;\">Syrup NVP + Syrup Zidovudine</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><u>Duration of Dual ARV Prophylaxis:</u></span></p><ul><li><span style=\"font-size:16px;\">In case of Exclusive Replacement Feeding (ERF): From birth till 6 weeks of age</span></li><li><span style=\"font-size:16px;\">In case of Exclusive Breastfeeding (EBF): From birth till 12 weeks of age</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">For newborns of untreated HIV-positive mothers, initial treatment includes Syrup NVP + Syrup Zidovudine 6 weeks (12 weeks in cases of exclusive breast feeding) to reduce the risk of mother-to-child HIV transmission.</span></p>",
      "correct_choice_id": 185437,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4489,
      "choices": [
        {
          "id": 17932,
          "text": "<p><span style=\"font-size:12pt;\">EEG</span></p>"
        },
        {
          "id": 17933,
          "text": "<p><span style=\"font-size:12pt;\">Provoked lower esophageal contractility</span></p>"
        },
        {
          "id": 17934,
          "text": "<p><span style=\"font-size:12pt;\">Entropy</span></p>"
        },
        {
          "id": 17935,
          "text": "<p><span style=\"font-size:12pt;\">Bispectral index</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which among the following monitors is most commonly used to monitor the depth of anesthesia?</span></p>",
      "unique_key": "Q4781627",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828553,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Bispectral index</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>The bispectral index</strong> (BIS) is the most commonly used method to monitor the depth of anesthesia and determine the level of consciousness under anesthesia.</span></li><li><span style=\"font-size:12pt;\">BIS is derived from the EEG (electroencephalogram) and shows the cerebral drug effect of an anesthetic drug.</span></li><li><span style=\"font-size:12pt;\">BIS values range from 0-100, where lower values indicate deeper anesthesia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. EEG:&nbsp;</strong>While EEG is the basis for BIS, it is not typically used directly in clinical practice to monitor anesthesia depth due to its complexity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Provoked lower esophageal contractility:&nbsp;</strong>This is not a standard or common method for monitoring the depth of anesthesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Entropy:&nbsp;</strong>Entropy monitoring is another EEG-based technique used to assess the depth of anesthesia. However, it is less commonly used compared to BIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The bispectral index (BIS) is the most commonly used monitor to assess the depth of anesthesia, providing an EEG-derived measure of the cerebral effects of anesthetic drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture70_8iI3h7S.jpg\" alt=\"\" width=\"1000\" height=\"207\"></span></p>",
      "correct_choice_id": 17935,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20824,
      "choices": [
        {
          "id": 83260,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspergillosis</span></p>"
        },
        {
          "id": 83261,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucormycosis</span></p>"
        },
        {
          "id": 83262,
          "text": "<p><span style=\"font-size:12.0pt;\">Foreign Body</span></p>"
        },
        {
          "id": 83263,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhinosporidiosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old female presented in OPD as shown below. She is a known case of Diabetes Mellitus. What is the most probable diagnosis?&nbsp;</span>(FMGE JANUARY 2023)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/picture55.jpg\" alt=\"\" width=\"300\" height=\"213\"></span></p>",
      "unique_key": "Q5221655",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828585,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Mucormycosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fungal Infection that can happen in uncontrolled DM – Mucormycosis, Aspergillosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mucormycosis</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Caused by mucor, rhizopus.</span></li><li><span style=\"font-size:12.0pt;\">Invades very rapidly to the surrounding tissue → into orbit → cranium</span></li><li><span style=\"font-size:12.0pt;\">Black eschars are formed</span></li><li><span style=\"font-size:12.0pt;\">Can be life-threatening if not attended immediately with surgical debridement, FESS and antifungal medication (Amphotericin-B).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspergillosis</strong>: This fungal infection can cause sinusitis but usually doesn't present with the rapid, aggressive invasion characteristic of mucormycosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Foreign Body and Option D. Rhinosporidiosis</strong>: These are less likely given the typical presentation and risk factors, and they don't typically present with the aggressive necrotic features seen in mucormycosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In diabetic patients presenting with black necrotic tissue and signs of invasive fungal infection in the nasal or orbital area, mucormycosis is the most likely diagnosis, requiring immediate and aggressive treatment to prevent potentially life-threatening complications.</span></p>",
      "correct_choice_id": 83261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14400,
      "choices": [
        {
          "id": 57561,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 1 or 2</span></p>"
        },
        {
          "id": 57562,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2 or 4</span></p>"
        },
        {
          "id": 57563,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2, 3, or 4</span></p>"
        },
        {
          "id": 57564,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the appropriate BIRADS category for a 23-year-old woman with a breast lump, no skin changes, and no indurations, whose histology shows a fibroadenoma appearance? (INICET NOV 2022)</span></p>",
      "unique_key": "Q4450552",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828558,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) BIRADS 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">BIRADS 2 is used for benign findings. Given that the histology shows a fibroadenoma appearance, which is a well-recognized benign breast condition, BIRADS 2 is the most suitable category for this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. BIRADS 1 or 2</strong>: BIRADS 1 is assigned to a category when there is no suspicion of malignancy, and BIRADS 2 is used when there is a benign finding. In this case, since the histology shows a fibroadenoma appearance, which is a benign breast condition, BIRADS 2 is the most appropriate category.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. BIRADS 2 or 4</strong>: BIRADS 4 is used when there is a suspicious abnormality that may or may not be cancerous. Since the histology in this case indicates a fibroadenoma appearance, which is benign, BIRADS 4 would not be appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>BIRADS 2, 3, or 4</strong>: BIRADS 3 is assigned when there is a probably benign finding that requires short-term follow-up. In this case, since the histology indicates a fibroadenoma appearance (a benign finding), BIRADS 3 and BIRADS 4 would not be applicable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of a 23-year-old woman with a breast lump, no skin changes, and no indurations, whose histology shows a fibroadenoma appearance, the appropriate BIRADS category is BIRADS 2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fibroadenoma is a benign tumor that poses a low risk of malignancy. The Breast Imaging Reporting and Data System (BIRADS) categories are used to assess the likelihood of malignancy of breast lesions seen on mammograms, ultrasounds, or MRI. Grades 1 and 2 have a very low probability of being malignant, while grade 3 has a slightly higher probability of malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Grades 4 and 5 are considered suspicious and warrant further investigation as they have a higher probability of malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-171804.jpg\" alt=\"\" width=\"1000\" height=\"494\"></span></p>",
      "correct_choice_id": 57564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54278,
      "choices": [
        {
          "id": 216581,
          "text": "<p><span style=\"font-size:12.0pt;\">Risedronate</span></p>"
        },
        {
          "id": 216582,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitriol</span></p>"
        },
        {
          "id": 216583,
          "text": "<p><span style=\"font-size:12.0pt;\">Lithium</span></p>"
        },
        {
          "id": 216584,
          "text": "<p><span style=\"font-size:12.0pt;\">Diuretics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following drugs decreases the serum parathyroid hormone levels?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1334958",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828582,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Calcitriol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Calcitriol is the active form of vitamin D and plays a crucial role in calcium and phosphate metabolism in the body. It directly acts on vitamin D receptors (VDRs) present in the parathyroid gland, leading to a decrease in the secretion of parathyroid hormone (PTH).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Action:</strong> Calcitriol increases the absorption of calcium and phosphate from the intestines. Elevated levels of calcium in the blood provide negative feedback to the parathyroid glands, which reduces the production of PTH. Additionally, calcitriol directly inhibits the synthesis and secretion of PTH by binding to VDRs in the parathyroid gland. This dual action ensures a reduction in PTH levels, making calcitriol an effective treatment for conditions associated with secondary hyperparathyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note - <strong>Paricalcitol</strong>: A synthetic vitamin D receptor (VDR) agonist used to reduce PTH levels in primary hyperparathyroidism. This drug is related to the <strong>Cinacalcet</strong>, a calcium sensitizer but this act on the calcium-sensing receptor (CaSR).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Risedronate:</strong> Risedronate is a bisphosphonate used to treat osteoporosis. It works by inhibiting osteoclast-mediated bone resorption, which can sometimes lead to hypocalcemia. Hypocalcemia can reflexively increase PTH levels, rather than decrease them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lithium:</strong> Lithium is known to cause unexplained hyperparathyroidism and consequently increase PTH levels. It is one of the common causes of unexplained hyperparathyroidism, making it an unsuitable option for decreasing PTH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diuretics:</strong> Diuretics, particularly loop diuretics, can cause hypocalcemia, which in turn can lead to an increase in PTH levels. Thiazide diuretics can cause hypercalcemia, which might decrease PTH levels, but in this question, \"diuretics\" is mentioned generally, and loop diuretics are more commonly associated with increased PTH levels due to hypocalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Calcitriol, the active form of vitamin D, decreases serum parathyroid hormone levels by increasing calcium absorption from the intestines and directly inhibiting PTH secretion from the parathyroid glands through its action on vitamin D receptors.</span></p>",
      "correct_choice_id": 216582,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57511,
      "choices": [
        {
          "id": 229417,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial nerve block</span></p>"
        },
        {
          "id": 229418,
          "text": "<p><span style=\"font-size:12.0pt;\">Axillary block</span></p>"
        },
        {
          "id": 229419,
          "text": "<p><span style=\"font-size:12.0pt;\">Bier’s block</span></p>"
        },
        {
          "id": 229420,
          "text": "<p><span style=\"font-size:12.0pt;\">Wrist block</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the image: (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-144929.jpg\" alt=\"\" width=\"400\" height=\"235\"></span></p>",
      "unique_key": "Q4628080",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828570,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Bier’s block</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image depicts the setup for a Bier’s block, also known as intravenous regional anesthesia (IVRA).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This technique is commonly used for short surgical procedures on the extremities, such as the hands or forearms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The process involves placing a double cuff tourniquet on the limb to occlude blood flow, then injecting a local anesthetic (such as lidocaine) into a vein in the isolated limb.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The tourniquet prevents the anesthetic from circulating out of the limb, thus providing anesthesia to the area. Bier's block is a fast and effective method for producing anesthesia in a limb without the need for general anesthesia or nerve blocks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Radial nerve block:</strong> A radial nerve block involves injecting anesthetic near the radial nerve . It does not involve a tourniquet or intravenous injection of local anesthetic as depicted in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Axillary block:</strong> An axillary block is a type of brachial plexus block where anesthetic is injected near the axillary artery to block the nerves supplying the upper limb.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Wrist block:</strong> A wrist block involves injecting local anesthetic near the nerves at the wrist to provide anesthesia to the hand. It is different from Bier's block and does not involve a tourniquet or intravenous injection as shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bier’s block, or intravenous regional anesthesia (IVRA), is used for anesthetizing a limb by injecting local anesthetic into a vein while using a tourniquet to confine the anesthetic to the limb.</span></p>",
      "correct_choice_id": 229419,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57511/Neet_Pg_Aug_2024_Anesthesia_Q_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ImageBased",
        "InstrumentsBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57511/Neet_Pg_Aug_2024_Anesthesia_Q_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13915,
      "choices": [
        {
          "id": 55621,
          "text": "<p><span style=\"font-size:12.0pt;\">Red nucleus</span></p>"
        },
        {
          "id": 55622,
          "text": "<p><span style=\"font-size:12.0pt;\">Sub thalamic nuclei</span></p>"
        },
        {
          "id": 55623,
          "text": "<p><span style=\"font-size:12.0pt;\">Decussation of pyramidal tract</span></p>"
        },
        {
          "id": 55624,
          "text": "<p><span style=\"font-size:12.0pt;\">Olivary nucleus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">At which level does the nerve supply for the marked structure arise? (</span>INICET May 2021)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture1_D7XdOGB.jpg\" alt=\"\" width=\"300\" height=\"169\"></p><p>&nbsp;</p>",
      "unique_key": "Q9215337",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Red nucleus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The medial rectus muscle is the one highlighted in the provided CT picture. The oculomotor nerve, whose nucleus is located at the level of the superior colliculus adjacent to the red nucleus, supplies the medial rectus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nuclear complex from which the oculomotor nerve arises consists of:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Several groups of large motor neurons are collectively called the oculomotor nucleus. The motor neuron groups of the oculomotor nucleus innervate, in dorsoventral order, the ipsilateral inferior rectus, inferior oblique, and medial rectus. A medially placed column of cells innervates the contralateral superior rectus.</span></li><li><span style=\"font-size:12.0pt;\">Smaller preganglionic parasympathetic neurons called the Edinger-Westphal preganglionic nucleus</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Subthalamic nuclei</strong>: The subthalamic nucleus is part of the diencephalon and is closely associated with the basal ganglia circuitry. It plays a role in motor control. It's not directly associated with the oculomotor nerve's origin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Decussation of pyramidal tract</strong>: The decussation of the pyramidal tract (motor fibers) occurs in the lower medulla oblongata, well below the level of the oculomotor nerve's origin. This is where the majority of motor fibers from one hemisphere cross to the opposite side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Olivary nucleus</strong>: The olivary nucleus is located in the medulla oblongata and is primarily associated with the coordination of motor tasks. Again, it's located caudally relative to the oculomotor nerve's origin in the midbrain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The oculomotor nerve (CN III) arises from the anterior aspect of the midbrain, at the level of the superior colliculus. Its nucleus is situated ventral to the cerebral aqueduct and in close proximity to the red nucleus. Hence, the oculomotor nerve is often associated with the level of the red nucleus in the midbrain. It exits the midbrain medial to the cerebral peduncle.</span></p>",
      "correct_choice_id": 55621,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2034,
      "choices": [
        {
          "id": 8129,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Beta Glucocerebrosidase - Von Gierke&rsquo;s </span></span></span></p>"
        },
        {
          "id": 8130,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Ceruloplasmin - Hepatolenticular degeneration </span></span></span></p>"
        },
        {
          "id": 8131,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">High LDH1/LDH2 - Myocardial Infarction</span></span></span></p>"
        },
        {
          "id": 8132,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Lipase - Pancreatitis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Which of the following enzymes/diagnostic marker is incorrectly paired?(INICET MAY 2021)</span></span></span></p>",
      "unique_key": "Q4649827",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828557,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Ans. A) Beta Glucocerebrosidase - Von Gierke&rsquo;s</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Defect in Beta glucocerebrosidase is associated with sphingolipid lysosomal storage disorder known as Gaucher&rsquo;s disease Whereas Von Gierke&rsquo;s disease is caused due to deficiency of enzyme Glucose-6-phosphatase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Hepatolenticular degeneration also known as Wilson&rsquo;s disease is due to defect in ATP7B gene causing defective biliary excretion of copper and accumulation of copper in liver. There is decrease in plasma ceruloplasmin serving as marker.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">In normal person, LDH-2 is more than LDH-1 in serum. BUT in myocardial infarction, LDH-1&gt;&gt;LDH-2. This is known as Flipped ratio of LDH in Myocardial Infarction. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Lipase and amylase are increased in plasma in case of Pancreatitis hence they serve as marker enzymes for pancreatitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Beta-glucocerebrosidase is linked to Gaucher&rsquo;s disease, not Von Gierke&rsquo;s disease, which is caused by a deficiency in Glucose-6-phosphatase. Correct pairing of diagnostic markers and associated conditions is crucial for accurate diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Ref - Harper 31<sup>st</sup> e/p 64, 167,634</span></strong>&nbsp; </span></span></p>",
      "correct_choice_id": 8129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10220,
      "choices": [
        {
          "id": 40846,
          "text": "<p><span style=\"font-size:12pt;\">Borderline Tuberculoid leprosy</span></p>"
        },
        {
          "id": 40847,
          "text": "<p><span style=\"font-size:12pt;\">Lepromatous leprosy</span></p>"
        },
        {
          "id": 40848,
          "text": "<p><span style=\"font-size:12pt;\">Borderline leprosy&nbsp;(BB Leprosy)</span></p>"
        },
        {
          "id": 40849,
          "text": "<p><span style=\"font-size:12pt;\">Histoid leprosy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The below-given image is characteristically seen in which of the following type of leprosy? (</span>INICET Nov 2021)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13554.jpg\" alt=\"\" width=\"300\" height=\"200\"></p>",
      "unique_key": "Q5940572",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828579,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;C) Borderline leprosy (BB Leprosy)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given image shows a case of <strong>borderline leprosy, or dimorphous</strong> leprosy, as evidenced by the <strong>inverted saucer</strong> shaped cutaneous lesions on the patient's skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Characteristics of Borderline Leprosy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Lesions:&nbsp;</strong>Borderline leprosy often presents with numerous skin lesions which may be macular (flat), papular (raised), or annular (ring-shaped) with less defined borders compared to tuberculoid leprosy. The lesions can sometimes exhibit an \"inverted saucer\" appearance, where the center appears slightly depressed.</span></li><li><span style=\"font-size:12pt;\"><strong>Symmetry:&nbsp;</strong>The lesions tend to be asymmetrical.</span></li><li><span style=\"font-size:12pt;\"><strong>Sensory Loss:&nbsp;</strong>These lesions usually show some sensory loss, although not as pronounced as in tuberculoid leprosy.</span></li><li><span style=\"font-size:12pt;\"><strong>Reactivity:&nbsp;</strong>Borderline leprosy is particularly unstable immunologically, prone to reactivations and shifts toward either more or less severe forms, depending on immune changes in the individual.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Borderline Tuberculoid Leprosy:&nbsp;</strong>Closer to the tuberculoid pole with fewer, well-defined lesions and significant nerve involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Lepromatous Leprosy:&nbsp;</strong>At the opposite pole from tuberculoid leprosy, characterized by numerous lesions including nodules and plaques, with a high bacterial load but minimal sensory loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Histoid Leprosy:&nbsp;</strong>A rare variant of lepromatous leprosy presenting as nodules and plaques, often occurring in patients who have experienced leprosy treatment or relapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Patients with borderline leprosy are at risk for developing reactions like Type 1 (reversal) reactions, which can lead to rapid worsening of lesions and require immediate medical attention.</span></li><li><span style=\"font-size:12pt;\">Accurate diagnosis based on clinical presentation, bacterial index, and histopathology is crucial as the treatment duration and regimen may differ based on the type of leprosy. Borderline leprosy is typically treated with multi-drug therapy (MDT), similar to other forms of leprosy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of Dermatology 9<sup>th</sup> edition page no 28.3, 28.5, 28.10</strong></span></p>",
      "correct_choice_id": 40848,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11197,
      "choices": [
        {
          "id": 44754,
          "text": "<p><span style=\"font-size:18px;\">Anopheles</span></p>"
        },
        {
          "id": 44755,
          "text": "<p><span style=\"font-size:18px;\">Aedes</span></p>"
        },
        {
          "id": 44756,
          "text": "<p><span style=\"font-size:18px;\">Mansonia</span></p>"
        },
        {
          "id": 44757,
          "text": "<p><span style=\"font-size:18px;\">Culex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Water has accumulated in a container from a malfunctioning septic system, and mosquito larvae are observed. Based on the provided larval image, which mosquito species is it likely to be? </strong><i><strong>[INICET NOV 2022]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip52.jpg\" alt=\"\" width=\"400\" height=\"241\"></strong></span></p>",
      "unique_key": "Q6856911",
      "question_audio": null,
      "question_video": null,
      "map_id": 19828563,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Culex</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Culex mosquito breeds in dirty water. The image shows a Culex larva with head suspended downwards at an angle to water surface and a siphon tube.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In Culex, siphon tube is long and narrow</span></li><li><span style=\"font-size:18px;\">In Aedes, it is short and broad</span></li><li><span style=\"font-size:18px;\">In Mansonia, larvae are attached through siphon tube to roots of aquatic plants</span></li><li><span style=\"font-size:18px;\">In Anopheles- No siphon tube but only apertures on 8<sup>th</sup>abdominal segment</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Breeding Habitant</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Anopheles → Sophisticated Mosquito; Breeds in clean water</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Culex → Nuisance Mosquito; <strong>Breeds in dirty water</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/untitled-2.jpg\" alt=\"\" width=\"1000\" height=\"709\"></strong></span></p>",
      "correct_choice_id": 44757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}